These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2392503)

  • 41. Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig.
    Harris AL; Connell MJ; Ferguson EW; Wallace AM; Gordon RJ; Pagani ED; Silver PJ
    J Pharmacol Exp Ther; 1989 Oct; 251(1):199-206. PubMed ID: 2552074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age-related effects of rolipram on [3H]quinuclidinyl benzilate and [3H]phorbol 12,13-dibutyrate binding in the rat brain.
    Chen T; Kato H; Araki T; Itoyama Y; Kogure K
    Tohoku J Exp Med; 1998 Jun; 185(2):107-18. PubMed ID: 9747650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of rolipram-sensitive cyclic AMP phosphodiesterase in the regulation of cardiac contraction.
    Muller B; Lugnier C; Stoclet JC
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):796-803. PubMed ID: 1703603
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [3H]Rolipram binding and phosphodiesterase activity in neuroblastoma N18TG-2 and glioma C6Bu-1.
    Tohda M; Murayama T; Hasegawa H; Nogiri S; Nomura Y
    Neurosci Lett; 1994 Jul; 175(1-2):89-91. PubMed ID: 7526296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Airway relaxant and anti-inflammatory properties of a PDE4 inhibitor with low affinity for the high-affinity rolipram binding site.
    Martin C; Göggel R; Dal Piaz V; Vergelli C; Giovannoni P; Ernst M; Uhlig S
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):284-9. PubMed ID: 11919652
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of cyclic nucleotide phosphodiesterase by derivatives of 1,3-bis(cyclopropylmethyl)xanthine.
    Buckle DR; Arch JR; Connolly BJ; Fenwick AE; Foster KA; Murray KJ; Readshaw SA; Smallridge M; Smith DG
    J Med Chem; 1994 Feb; 37(4):476-85. PubMed ID: 8120866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity in vitro and eosinophil trafficking in vivo.
    Cooper N; Teixeira MM; Warneck J; Miotla JM; Wills RE; Macari DM; Gristwood RW; Hellewell PG
    Br J Pharmacol; 1999 Apr; 126(8):1863-71. PubMed ID: 10372831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase (PDE IV) in the ferret.
    Robichaud A; Tattersall FD; Choudhury I; Rodger IW
    Neuropharmacology; 1999 Feb; 38(2):289-97. PubMed ID: 10218871
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mapping of second messenger and rolipram receptors in mammalian brain.
    Araki T; Kato H; Kogure K
    Brain Res Bull; 1992 Jun; 28(6):843-8. PubMed ID: 1322228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brain cAMP response to phosphodiesterase inhibitors in rats killed by microwave irradiation or decapitation.
    Schneider HH
    Biochem Pharmacol; 1984 May; 33(10):1690-3. PubMed ID: 6203537
    [No Abstract]   [Full Text] [Related]  

  • 51. The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4.
    Hughes B; Howat D; Lisle H; Holbrook M; James T; Gozzard N; Blease K; Hughes P; Kingaby R; Warrellow G; Alexander R; Head J; Boyd E; Eaton M; Perry M; Wales M; Smith B; Owens R; Catterall C; Lumb S; Russell A; Allen R; Merriman M; Bloxham D; Higgs G
    Br J Pharmacol; 1996 Jul; 118(5):1183-91. PubMed ID: 8818342
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory.
    Barad M; Bourtchouladze R; Winder DG; Golan H; Kandel E
    Proc Natl Acad Sci U S A; 1998 Dec; 95(25):15020-5. PubMed ID: 9844008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antidepressant-like effects of rolipram and other inhibitors of cyclic adenosine monophosphate phosphodiesterase on behavior maintained by differential reinforcement of low response rate.
    O'Donnell JM
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1168-78. PubMed ID: 8383740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic treatment with the potential antidepressant drug rolipram: the effect on the behavioural responses to adrenergic and dopaminergic receptor agonists with some biochemical correlates.
    Przegaliński E; Baran L; Siwanowicz J; Nowak G; Antkiewicz-Michaluk L; Vetulani J
    J Neural Transm; 1985; 64(3-4):211-26. PubMed ID: 3003251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Investigations of the dual contractile/relaxant properties showed by antioquine in rat aorta.
    Ivorra MD; Lugnier C; Catret M; Anselmi E; Cortes D; D'Ocon P
    Br J Pharmacol; 1993 Jun; 109(2):502-9. PubMed ID: 8358549
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis.
    Sommer N; Löschmann PA; Northoff GH; Weller M; Steinbrecher A; Steinbach JP; Lichtenfels R; Meyermann R; Riethmüller A; Fontana A
    Nat Med; 1995 Mar; 1(3):244-8. PubMed ID: 7585041
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Absence of anticholinergic activity of rolipram, an antidepressant with a novel mechanism of action, in three different animal models in vivo.
    Wachtel H; Löschmann PA; Pietzuch P
    Pharmacopsychiatry; 1988 Sep; 21(5):218-21. PubMed ID: 3227052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autoradiographic analysis of cyclic adenosine monophosphate phosphodiesterase using [3H]rolipram in the postischemic rat brain.
    Nagasawa H; Araki T; Kogure K
    Neurosci Lett; 1992 Sep; 144(1-2):34-7. PubMed ID: 1331913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence that cyclic AMP phosphodiesterase inhibitors suppress interleukin-2 release from murine splenocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer.
    Souness JE; Houghton C; Sardar N; Withnall MT
    Br J Pharmacol; 1997 Jun; 121(4):743-50. PubMed ID: 9208143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.